GSK2983559 free acid
CAS No. 1579965-12-0
GSK2983559 free acid ( —— )
Catalog No. M26238 CAS No. 1579965-12-0
GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 87 | Get Quote |
|
10MG | 135 | Get Quote |
|
25MG | 226 | Get Quote |
|
50MG | 338 | Get Quote |
|
100MG | 507 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK2983559 free acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2).
-
DescriptionGSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2). GSK2983559 free acid shows excellent activity in blocking many proinflammatory cytokine responses in human inflammatory bowel disease explant samples.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorleucyl-tRNA synthetase; Ras-related GTP-binding protein D (RagD)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1579965-12-0
-
Formula Weight538.5
-
Molecular FormulaC21H23N4O7PS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCOP(O)(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jong Hyun Kim, et al. Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction. Nat Commun. 2017 Sep 29;8(1):732.
molnova catalog
related products
-
Licochalcone E
Licochalcone E is a potential LXRβ agonist.
-
Cystamine dihydrochl...
Cystamine dihydrochloride is a radiation-protective agent. It also protects against carbon tetrachloride liver damage.
-
DSP-4 hydrochloride
DSP-4 hydrochloride (Neurotoxin DSP 4 hydrochloride) can be used for the temporary selective degradation of the central and peripheral noradrenergic neurons, mainly those from the locus coeruleus (LC).